Partner with us

Genomic Intelligence for Cancer Discovery

By partnering with leading academic and pharmaceutical researchers, we are creating clinical tools for physicians, identifying patient populations for novel therapeutics, and enabling clinical trials with the goal of improving patient outcomes.

Derive insights from population-level genomics

Better understand the dynamics of pathways and intricate biomarkers such as androgen receptor activity, DNA repair, immune profiling or chemotherapy response activation.

Reveal new biomarkers through comprehensive genomic profiling

We can profile your cohorts using the whole-transcriptome platform in our CLIA-certified, CAP-accredited, NYS-approved laboratory. With this service, you also gain access to the full repertoire of signatures from the GRID.

Enable clinical trials in earlier patient populations

Utilize more than 500 genomic signatures and 110,000 profiles in the GRID database to identify new niche populations for clinical trial design.

Senior man holding up and staring at a red and white pill.

Commercialize your therapies faster

Screen and identify patients efficiently for clinical trial enrollment through our prospective profiling of hundreds of patients per week.

Partner With Us


Fax: 1.858.766.6575

Customer Support:

Business and partnership inquiries:

Managed care inquiries: